Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes. - Test2 - elhamkhani - TriplyDB

Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes.

Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes.

http://www.wikidata.org/entity/Q36477239

about

Molecular mechanisms regulating NLRP3 inflammasome activation New mechanisms of metformin action: Focusing on mitochondria and the gut Is immunity a mechanism contributing to statin-induced diabetes?The mitochondria in diabetic heart failure: from pathogenesis to therapeutic promise Linking obesity with type 2 diabetes: the role of T-bet Endothelial dysfunction: the role of sterol regulatory element-binding protein-induced NOD-like receptor family pyrin domain-containing protein 3 inflammasome in atherosclerosis Inflammasomes: mechanism of action, role in disease, and therapeutics Adipose tissue as an immunological organ Metabolically healthy and unhealthy obese--the 2013 Stock Conference report Diabetes propels the risk for cardiovascular disease: sweet monocytes becoming aggressive?Endocannabinoid regulation of β-cell functions: implications for glycaemic control and diabetes Extracellular microRNAs and endothelial hyperglycaemic memory: a therapeutic opportunity?Minireview: Emerging Concepts in Islet Macrophage Biology in Type 2 Diabetes Exposure to nickel oxide nanoparticles induces pulmonary inflammation through NLRP3 inflammasome activation in rats Inflammasomes and metabolic disorders: old genes in modern diseases Reactive oxygen species-induced TXNIP drives fructose-mediated hepatic inflammation and lipid accumulation through NLRP3 inflammasome activation Molecular and Cellular Mechanisms of Cardiovascular Disorders in Diabetes Defective mitophagy driven by dysregulation of rheb and KIF5B contributes to mitochondrial reactive oxygen species (ROS)-induced nod-like receptor 3 (NLRP3) dependent proinflammatory response and aggravates lipotoxicity Maresin 1 Mitigates High Glucose-Induced Mouse Glomerular Mesangial Cell Injury by Inhibiting Inflammation and Fibrosis IL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone?Inflammatory Effects of the Plant Protection Product Stifenia (FEN560) on Vertebrates Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes.Globular Adiponectin Inhibits Lipopolysaccharide-Primed Inflammasomes Activation in Macrophages via Autophagy Induction: The Critical Role of AMPK Signaling.Role of innate immunity in the pathogenesis of type 1 and type 2 diabetes.Convergence of innate immunity and insulin resistance as evidenced by increased nucleotide oligomerization domain (NOD) expression and signaling in monocytes from patients with type 2 diabetes.Inflammasomes in neuroinflammation and changes in brain function: a focused review.High-density lipoprotein: a novel target for antirestenosis therapy Novel CoQ10 antidiabetic mechanisms underlie its positive effect: modulation of insulin and adiponectine receptors, Tyrosine kinase, PI3K, glucose transporters, sRAGE and visfatin in insulin resistant/diabetic rats.NLRP3 gene silencing ameliorates diabetic cardiomyopathy in a type 2 diabetes rat model.Endoplasmic reticulum stress is increased in adipose tissue of women with gestational diabetes.Capsular Polysaccharide Is Involved in NLRP3 Inflammasome Activation by Klebsiella pneumoniae Serotype K1 Fasting and refeeding differentially regulate NLRP3 inflammasome activation in human subjects.Suppression of NLRP3 inflammasome by γ-tocotrienol ameliorates type 2 diabetes Maladaptive Modulations of NLRP3 Inflammasome and Cardioprotective Pathways Are Involved in Diet-Induced Exacerbation of Myocardial Ischemia/Reperfusion Injury in Mice.Shiga Toxins Activate the NLRP3 Inflammasome Pathway To Promote Both Production of the Proinflammatory Cytokine Interleukin-1β and Apoptotic Cell Death.Study on inflammation-related genes and microRNAs, with special emphasis on the vascular repair factor HGF and miR-574-3p, in monocytes and serum of patients with T2D.Nlrp3 inflammasome activation in type 2 diabetes: is it clinically relevant?Mechanisms of disease: inflammasome activation and the development of type 2 diabetes.Characterization and Activation of NLRP3 Inflammasomes in the Renal Medulla in Mice.A pharmacological inhibitor of NLRP3 inflammasome prevents non-alcoholic fatty liver disease in a mouse model induced by high fat diet.

P2860

Q26778556-694E9D58-4992-492A-97A4-0990ACA3BABE Q26778766-8D779843-A822-4E6B-B7E6-7B4DD78CAAF5 Q26785561-4F7184FE-BA19-49FC-A124-4E3F1C9FAFFF Q26829731-5ED7FA46-9590-42FB-9DFA-69D53B9104EB Q26830915-8FAC0A2B-B6B0-42BD-BABC-3F6907B31C09 Q26852572-CC153290-AE7C-4050-AA43-0E377D86C345 Q27001186-0EA0DED5-1968-4A97-BEBD-DA7959862415 Q27003461-191D8AF5-E12D-4E93-B350-AD0D4DDC7A95 Q27021552-87918ACB-6024-4156-9CAE-7267AEF5E425 Q28072462-4E28C30C-71B9-4865-BE60-31EFF6892E04 Q28078897-F94888D0-0349-468A-A2E9-BD650D79FF19 Q28079163-B34094C5-962A-45ED-ACD0-8810886B0C38 Q28083768-17E5E559-011B-4808-93CD-9DE6137DB749 Q28385332-B957BD44-86AC-4BD1-937E-46E78EE807E0 Q28389531-39C804C7-EC11-4C64-BF59-560817BCD547 Q28390197-0CD89AFD-49F8-4A69-9A82-7D9950B45C6E Q28395675-04BA262A-B8D3-4634-9491-F70893AD879B Q28575583-E9AB3DDB-C435-42ED-BA83-2F4620604AF5 Q29248428-53CA31C6-DD4A-42BF-949E-1FC61621EC82 Q30251741-72CC1E0F-93A2-4A36-A55B-AE1D11F1C1F8 Q33594099-1191E99B-5FA4-44D9-99E7-993527E5A99B Q33731729-F59B9423-B4CF-4F7F-8A1A-C86589073ADA Q33838982-F88FF9D6-6AC7-4253-AC71-5B9B48B38FC1 Q34029902-E2E29D30-1CED-4B73-AD75-216A9E74EF40 Q34150760-1F202BE0-7203-48B9-AA61-5D4BCE754CC7 Q34299338-765A9BAE-F63D-4D81-8897-19A45A6AB160 Q34714464-2CB18D2E-392A-4A3E-A803-9A4F912C770D Q35106778-1C3D9AE1-C8F3-4776-8E5A-497386406FC0 Q35227844-79645E08-2A44-44EA-A978-C2F7A179E22A Q35306325-BEBC98C5-4EB6-4986-8A5B-E898D0CC626C Q35947488-D2F2A1AE-2D10-47EA-93B3-D8967296263B Q36335877-22F1F878-37F0-49C4-BB6D-914242392B01 Q36399235-CCFF636F-B9F4-48EF-910B-C1D3994B526B Q36405678-EDD854A2-8090-4C8A-92E6-FC8AAF708512 Q36410999-DBFDF6B3-4530-4A70-8ADF-A6807AE6F7AE Q36466672-12101014-D55B-4FBD-ACEE-37C242BD9FDD Q36477290-EE525B16-F664-4709-83AA-9C8444A1D4B2 Q36668052-3CCDB2A3-70BC-46FE-9CFF-F476703B8694 Q36777354-20881441-CCB6-4472-9CD4-4DEB67EFD3A1 Q36796097-E71EC7D5-2866-4288-8625-1EA15BE0C5C6

P2860

Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes.

http://www.wikidata.org/entity/Q36477239

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes.

@ast

Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes.

@en

type

label

Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes.

@ast

Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes.

@en

prefLabel

Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes.

@ast

Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes.

@en

P1433

Q36477239-C9C3D99A-2BEE-45D2-9A57-463CE0DAC2F2

P1476

Q36477239-59AB7364-D43C-4FBB-88A6-A7794106762C

P2093

Q36477239-045E4D83-8329-4368-8EA0-B4C5732D4799

Q36477239-37918EEA-9943-460C-81BC-4EF3753860C0

Q36477239-7D201FDC-03DB-4A3F-BBC9-3F5A05E2113D

Q36477239-A07DB195-E502-4620-975C-DF7CFF1C472D

Q36477239-F2EB3342-767E-489D-BE7B-12F67E4A5647

P2860

Q36477239-03B30073-4B27-45BB-8DB1-B9939D05D515

Q36477239-04E0972B-7346-4ED1-BAB7-0BFE531349E9

Q36477239-06D55EF9-255E-47FD-8E6D-EE7F22ECF441

Q36477239-0C0994D9-2089-4F9B-93B9-8627E427BDF2

Q36477239-0D24B1B6-2F22-48AC-AC67-A9377E0AC627

Q36477239-15A80336-282F-4DB3-823D-2F5CE989623E

Q36477239-1A1716DF-ACFB-46F2-A080-952F0A6F023C

Q36477239-23BF1E5A-C0CA-4B95-A26A-B233B2CEC984

Q36477239-2608D991-6AF0-42DA-9549-B234239C8495

Q36477239-2F08997D-217B-434B-98F1-2B1D510921FC

P304

Q36477239-12DC5202-7671-4B2D-AFAE-F150889F761E

P31

Q36477239-BEE769FE-0E60-4389-B392-0C55ACA9B79C

P356

Q36477239-4D086D44-2C58-44B8-85E8-7A545009FC11

P407

Q36477239-9D1AD6E6-8E2E-4225-A7AD-5A1ECDBA7146

P433

Q36477239-8EDF030A-22BC-4B24-855B-C0917317357A

P478

Q36477239-39889139-E6B4-4015-A3D7-1B005946CACE

P50

Q36477239-E34C866E-1EDC-430A-8C51-93BDC14F8E8F

P577

Q36477239-376C4189-0077-4A92-8BDC-895ACE8E73D2

P5875

Q36477239-B5E3A762-24E7-4A3D-98DE-BCB6CC319A0A

P698

Q36477239-6AADCAB4-DBB9-46FC-9E31-DE5B5236079F

P921

Q36477239-79437E21-96B3-4154-8C76-595CA642548E

Q36477239-A705F2D7-A7DF-4D07-AB58-0A74745BC482

P932

Q36477239-73E62666-4EC6-4667-BCA5-0355676C3F09

P356

P1433

P1476

Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes

@en

P2093

Bon Jeong Ku

http://www.w3.org/2001/XMLSchema#string

Eun-Kyeong Jo

http://www.w3.org/2001/XMLSchema#string

Hye-Mi Lee

http://www.w3.org/2001/XMLSchema#string

Hyun Jin Kim

http://www.w3.org/2001/XMLSchema#string

Jwa-Jin Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Metformin Increases AMP-Activated Protein Kinase Activity in Skeletal Muscle of Subjects With Type 2 Diabetes

Inflammation and insulin resistance

Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome

Inflammasomes: too big to miss

Cellular and molecular mechanisms of metformin: an overview

Type 2 diabetes can be prevented with early pharmacological intervention

A role for mitochondria in NLRP3 inflammasome activation

Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome

Thioredoxin-interacting protein links oxidative stress to inflammasome activation

Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling

P304

194-204

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DB12-0420

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

62

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-10-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232532961

http://www.w3.org/2001/XMLSchema#string

P698

23086037

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

3526026

http://www.w3.org/2001/XMLSchema#string